Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2020646 | Protein Expression and Purification | 2012 | 4 Pages |
Expressed protein ligation (EPL) was performed to investigate sequence requirements for a variant human apolipoprotein A-I (apoA-I) to adopt a folded structure. A C-terminal truncated apoA-I, corresponding to residues 1–172, was expressed and isolated from Escherichia coli. Compared to full length apoA-I (243 amino acids), apoA-I(1–172) displayed less α-helix secondary structure and lower stability in solution. To determine if extension of this polypeptide would confer secondary structure content and/or stability, 20 residues were added to the C-terminus of apoA-I(1–172) by EPL, creating apoA-IMilano(1–192). The EPL product displayed biophysical properties similar to full-length apoA-IMilano. The results provide a general protein engineering strategy to modify the length of a recombinant template polypeptide using synthetic peptides as well as a convenient, cost effective way to investigate the structure/function relations in apolipoprotein fragments or domains of different size.
► Apolipoprotein structure and function. ► Expressed protein ligation template extension. ► Apolipoprotein A-I Milano variant as a therapeutic.